Evidence map›Paper›PMID 30487216›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Translational switching of Cry1 protein expression confers reversible control of circadian behavior in arrhythmic Cry-deficient mice.

Elizabeth S Maywood, Thomas S Elliott, Andrew P Patton, Toke P Krogager, Johanna E Chesham, Russell J Ernst, Václav Beránek, Marco Brancaccio, Jason W Chin, Michael H Hastings

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Astrocytic control of extracellular GABA drives circadian timekeeping in the suprachiasmatic nucleus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Article
  15. Mathematical Modeling in Circadian Rhythmicity.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Therapeutic promise of engineered nonsense suppressor tRNAs.Wiley interdisciplinary reviews. RNA · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Elizabeth S MaywoodDivision of Neurobiology, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom; emaywood@mrc-lmb.cam.ac.uk mha@mrc-lmb.cam.ac.uk.ORCID 0000-0002-4557-9955
Thomas S ElliottDivision of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.
Andrew P PattonDivision of Neurobiology, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.ORCID 0000-0003-2666-4254
Toke P KrogagerDivision of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.
Johanna E CheshamDivision of Neurobiology, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.
Russell J ErnstDivision of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.
Václav BeránekDivision of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.
Marco BrancaccioDivision of Neurobiology, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.
Jason W ChinDivision of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom.
Michael H HastingsDivision of Neurobiology, Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, United Kingdom; emaywood@mrc-lmb.cam.ac.uk mha@mrc-lmb.cam.ac.uk.ORCID 0000-0001-8576-6651
MRC Laboratory of Molecular Biology · GB

Funding

Medical Research Council MC_U105170643Medical Research Council MC_U105181009Medical Research Council MC_UP_A024_1008
6 · The paper itself

Abstract

The suprachiasmatic nucleus (SCN) is the principal circadian clock of mammals, coordinating daily rhythms of physiology and behavior. Circadian timing pivots around self-sustaining transcriptional-translational negative feedback loops (TTFLs), whereby CLOCK and BMAL1 drive the expression of the negative regulators Period and Cryptochrome (Cry). Global deletion of Cry1 and Cry2 disables the TTFL, resulting in arrhythmicity in downstream behaviors. We used this highly tractable biology to further develop genetic code expansion (GCE) as a translational switch to achieve reversible control of a biologically relevant protein, Cry1, in the SCN. This employed an orthogonal aminoacyl-tRNA synthetase/tRNA

Indexed as

AnimalsChronobiology DisordersCircadian ClocksCircadian RhythmCryptochromesGene Expression RegulationMaleMiceMice, Inbred C57BLMice, KnockoutPeriod Circadian ProteinsProtein BiosynthesisProtein Processing, Post-TranslationalSuprachiasmatic NucleusTranscription FactorsCry1 protein, mouseCryptochromesPeriod Circadian ProteinsTranscription Factorsamber suppressioncircadiancryptochromegenetic code expansionsuprachiasmatic nucleus

Identifiers

PMID30487216
PMCPMC6310849
OpenAlexW2901993517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.